Design Therapeutics Inc DSGN:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/17/22 EDT
23.27UNCH (UNCH)
Volume
137,302
52 week range
9.61 - 26.30
Loading...
  • Open23.21
  • Day High23.94
  • Day Low22.61
  • Prev Close23.27
  • 52 Week High26.30
  • 52 Week High Date08/15/22
  • 52 Week Low9.61
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap1.299B
  • Shares Out55.81M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change8.69

KEY STATS

  • Open23.21
  • Day High23.94
  • Day Low22.61
  • Prev Close23.27
  • 52 Week High26.30
  • 52 Week High Date08/15/22
  • 52 Week Low9.61
  • 52 Week Low Date05/12/22
  • Market Cap1.299B
  • Shares Out55.81M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change8.69

RATIOS/PROFITABILITY

  • EPS (TTM)-0.91
  • P/E (TTM)-25.48
  • Fwd P/E (NTM)-19.87
  • EBITDA (TTM)-51.186M
  • ROE (TTM)-13.35%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Design Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Design Therapeutics, Inc. is a preclinical-stage biopharmaceutical company. The Company is focused on gene-targeted chimeras (GeneTAC) molecules, which is a class of small-molecule gene-targeted chimera therapeutic candidates that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. The Company's lead product candidate is Friedreich ataxia (FA). The Company is also developing the GeneTAC program in myotonic...
Pratik Shah Ph.D.
Executive Chairperson of the Board
Joao Siffert M.D.
President, Chief Executive Officer, Director
Sean Jeffries Ph.D.
Chief Operating Officer
Address
6005 Hidden Valley Road, Suite 110
Carlsbad, CA
92011
United States

Top Peers

SYMBOLLASTCHG%CHG
SWTX
SpringWorks Therapeutics Inc
28.50-1.65-5.47%
ZNTL
Zentalis Pharmaceuticals Inc
25.68-2.23-7.99%
MDGL
Madrigal Pharmaceuticals Inc
74.55-2.48-3.22%
PCVX
Vaxcyte Inc
25.04-0.38-1.49%
AGIO
Agios Pharmaceuticals Inc
26.22-1.19-4.34%